Tango Therapeutics, Inc. (TNGX) News
Latest headlines that mention TNGX, newest first · each headline opens the original publisher
- Last price
- $27.27
- Day change
- +1.07%
- Next earnings
- 2026-11-03
TNGX headlines
latest coverageTango Therapeutics Inc. jumped as much as 48% after initial results of a study showed a combination of its drug and a Revolution Medicines Inc. medicine shrunk tumors in advanced pancreatic cancer patients.
Tango Therapeutics stock skyrocketed Monday after the biotech company added to the Revolution Medicines' results in pancreatic cancer. The post Tango Skyrockets On Eye-Popping Pancreatic Cancer Results appeared first on Investor's Business Daily .
This biotechnology firm advances targeted cancer therapies, leveraging genetic insights and strategic partnerships in oncology.
Also mentioned with TNGX
30d
Headlines that tag both tickers
TNGX news alerts
Get an alert by email or push when a new headline mentions TNGX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.